E2 Completes Enrollment for Revolutionary Pulmonary Embolism Treatment Study E2 completes patient enrollment in the pivotal ENGULF study for its Hēlo™ PE Thrombectomy System, aimed at treating life-threatening pulmonary embolism.

E2 Completes Enrollment for Revolutionary Pulmonary Embolism Treatment Study #USA #Menlo_Park #Endovascular_Engineering #Hēlo_Thrombectomy #Pulmonary_Embolism

Endovascular Engineering Secures $42 Million to Revolutionize Pulmonary Embolism Treatment Endovascular Engineering has successfully raised $42 million in funding to enhance its innovative technology aimed at treating pulmonary embolism, supporting groundbreaking advancements in healthcare.

Endovascular Engineering Secures $42 Million to Revolutionize Pulmonary Embolism Treatment #United_States #Menlo_Park,_California #Endovascular_Engineering #Hēlo_Thrombectomy #Pulmonary_Embolism